Home › Drug maker Transcept rejects Shkreli play to boost ownership stake
 

Keywords :   


Drug maker Transcept rejects Shkreli play to boost ownership stake

2013-10-01 04:47:27| Biotech - Topix.net

Transcept Pharmaceuticals Inc. rejected a request from Retrophin Inc. to triple its ownership stake in the Richmond drug developer from 4.9 percent to up to 15 percent.

Tags: play drug ownership maker

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Post-Tropical Cyclone Helene Public Advisory Number 19
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 9
28.09Hurricane Isaac Forecast Advisory Number 9
28.09Hurricane Isaac Public Advisory Number 9
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Tropical Storm Joyce Forecast Discussion Number 3
More »